Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience

Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience

Abstract Background T2Dx was approved by the US Food and Drug Administration for the rapid detection of a modified panel of ESKAPE bacterial species or Candida spp. causing bloodstream infection (BSI). Patients and methods We performed a retrospective, observational study from January 1, 2018 to Dec...

Full description

Bibliographic Details
Main Authors: Angela Quirino, Vincenzo Scaglione, Nadia Marascio, Maria Mazzitelli, Eugenio Garofalo, Francesca Divenuto, Francesca Serapide, Andrea Bruni, Rosaria Lionello, Grazia Pavia, Chiara Costa, Aida Giancotti, Cinzia Peronace, Federico Longhini, Alessandro Russo, Maria Carla Liberto, Giovanni Matera, Carlo Torti, Enrico Maria Trecarichi
Format: Article
Language:English
Published: BMC 2022-02-01
Series:BMC Infectious Diseases
Subjects:
Blood stream infections
T2Dx
ESKAPE
Antimicrobial therapy
Online Access:https://doi.org/10.1186/s12879-022-07096-w

Internet

https://doi.org/10.1186/s12879-022-07096-w

Similar Items